CD4 and Patent ductus arteriosus: Moreover, akin to depleting DC, targeting IL-27 and iNOS were tumor protective in PDA and abrogated many elements of the characteristic CD4+ T-cell Tr1-like surface phenotype and cytokine profile in the TME, although mechanistic links to specific DCs subsest remains to be defined in vivo.